Canbisol

Canbisol

Clinical data
ATC code	none
Identifiers
IUPAC name (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromene-1,9-diol
CAS Number	56689-43-1 Y
PubChem CID	41969
ChemSpider	16736847 N
UNII	NZ1ZPC4WSF
ChEMBL	CHEMBL2105525 N
Chemical and physical data
Formula	C24H38O3
Molar mass	374.555 g/mol
3D model (Jmol)	Interactive image
SMILES Oc1cc(C(C)(C)CCCCCC)cc(c1C2C3)OC(C)(C)C2CCC3O
InChI InChI=1S/C24H38O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,17-19,25-26H,6-12,15H2,1-5H3/t17?,18-,19-/m0/s1 N Key:UEKGZFCGRQYMRM-MNNMKWMVSA-N N
NY (what is this?)

Canbisol (Nabidrox), is a synthetic cannabinoid derivative that is the dimethylheptyl homologue of 9-nor-9β-hydroxyhexahydrocannabinol (HHC). It is a potent agonist at both the CB₁ and CB₂ receptors, with a binding affinity of 0.1nM at CB₁ and 0.2nM at CB₂. It is mainly used in scientific research, in receptor binding studies to determine the structure and function of the cannabinoid receptors, but has been made illegal in some countries due to its possible abuse potential as a cannabinomimetic drug.